Aldeyra Therapeutics Reports Full Year 2015 Financial Results
March 30, 2016 07:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., March 30, 2016 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics to Present at the 2016 SSADH Symposium
March 24, 2016 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., March 24, 2016 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics Schedules Webcast and Conference Call for Fourth Quarter and Full Year 2015 Financial Results
March 16, 2016 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., March 16, 2016 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics to Present at the Cowen and Company 36th Annual Health Care Conference
March 03, 2016 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., March 03, 2016 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics Reports Positive Results From Phase IIa Clinical Trial in Subjects With Allergic Conjunctivitis
February 29, 2016 07:00 ET
|
Aldeyra Therapeutics
NS2 Demonstrates Statistically Significant and Sustained Clinical EffectsData Suggest Aldehyde Trapping as Novel Approach for the Treatment of Inflammatory DiseasesConference Call to Be Held Today at...
Aldeyra Therapeutics Appoints Mary Taylor, MPH as Senior Vice President, Regulatory Affairs
February 09, 2016 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., Feb. 09, 2016 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics Appoints David J. Clark, M.D. as Chief Medical Officer
January 11, 2016 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics Announces Last Patient Dosed in Phase II Trial of NS2 in Patients with Allergic Conjunctivitis
December 16, 2015 08:36 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., Dec. 16, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics to Present at the 27th Annual Piper Jaffray Healthcare Conference
November 24, 2015 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., Nov. 24, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics Reports Third Quarter and Year to Date 2015 Financial and Operating Results
November 12, 2015 07:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., Nov. 12, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...